Approximately 20–30% of human breast cancers overexpress HER2 receptors by amplification of the HER2/neu gene, which is a marker of aggressive cancer with an unfavorable prognosis that correlates with tumorigenesis and metastasis4, 5, 6, 7. The gene discussed is ERBB2; the disease is cancer.